Mercator Medical
ISIN: PLMRCTR00015 | Ticker: MRC | LEI: 259400YONW18M3H4WX66
Country: Poland
The Mercator Medical Group is a company from Kraków with Polish capital that officially opened its business in the medical devices market in 1996.
It is one of the two companies in Europe and also one of the few companies in the world that distribute both disposable medical supplies and disposable gloves.
The Group is now one of the most important players on the international scene.
It sells its products to approximately 70 countries in the world and distributes them in Europe.
For over 25 years of its operations, the company has successively established the MERCATOR brand, which is both highly recognisable and well-trusted in the medical industry.
Our portfolio includes a wide range of medical and protective gloves and nonwoven products as well as products from reputable international companies that are distributed exclusively by us.
1989
Served areaWorldwide
HeadquartersH.Modrzejewskiej 30, 31-327 Kraków – Poland
| Line item in (pln) | 02.01.2020 | 01.01.2021 | 02.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|---|
| Assets | N/A | 1,289,312,000.00 | N/A | 1,288,523,000.00 | N/A |
| Noncurrent Assets | N/A | 193,793,000.00 | N/A | 374,352,000.00 | N/A |
| Property Plant And Equipment | N/A | 183,413,000.00 | N/A | 336,229,000.00 | N/A |
| Intangible Assets Other Than Goodwill | N/A | 3,871,000.00 | N/A | 9,649,000.00 | N/A |
| Investments In Subsidiaries Joint Ventures And Associates | N/A | 0.00 | N/A | 0.00 | N/A |
| Other Noncurrent Receivables | N/A | 22,000.00 | N/A | 99,000.00 | 60,000.00 |
| Deferred Tax Assets | N/A | 6,487,000.00 | N/A | 28,375,000.00 | N/A |
| Current Assets | N/A | 1,095,519,000.00 | N/A | 914,171,000.00 | N/A |
| Inventories | N/A | 207,000,000.00 | N/A | 230,395,000.00 | N/A |
| Trade And Other Current Receivables | N/A | 339,513,000.00 | N/A | 143,637,000.00 | N/A |
| Current Tax Assets Current | N/A | 49,000.00 | N/A | 4,838,000.00 | N/A |
| Other Current Financial Assets | N/A | 149,117,000.00 | N/A | 195,695,000.00 | N/A |
| Cash and cash equivalents | 14,783,000.00 | 399,840,000.00 | 399,840,000.00 | 339,606,000.00 | 223,344,000.00 |
| Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | N/A | 1,095,519,000.00 | N/A | 914,171,000.00 | N/A |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | N/A | 0.00 | N/A | 0.00 | N/A |
| Current Restricted Cash And Cash Equivalents | N/A | 263,000.00 | N/A | 283,000.00 | 87,061,000.00 |
| Equity And Liabilities | N/A | 1,289,312,000.00 | N/A | 1,288,523,000.00 | N/A |
| Equity | 134,460,000.00 | 1,043,140,000.00 | N/A | 1,145,207,000.00 | N/A |
| Issued Capital | N/A | 10,604,000.00 | N/A | 10,647,000.00 | N/A |
| Retained Earnings | N/A | 963,763,000.00 | N/A | 1,078,634,000.00 | N/A |
| Share Premium | N/A | 57,139,000.00 | N/A | 57,843,000.00 | N/A |
| Other Reserves | N/A | 123,000.00 | N/A | 142,000.00 | N/A |
| Reserve Of Sharebased Payments | N/A | N/A | N/A | 142,000.00 | 142,000.00 |
| Equity Attributable To Owners Of Parent | N/A | 1,039,960,000.00 | N/A | 1,143,849,000.00 | N/A |
| Noncontrolling Interests | N/A | 3,180,000.00 | N/A | 1,358,000.00 | N/A |
| Liabilities | N/A | 246,172,000.00 | N/A | 143,316,000.00 | N/A |
| Noncurrent Liabilities | N/A | 6,282,000.00 | N/A | 10,262,000.00 | N/A |
| Noncurrent Provisions | N/A | 1,099,000.00 | N/A | 2,163,000.00 | N/A |
| Deferred Tax Liabilities | N/A | 2,957,000.00 | N/A | 4,348,000.00 | N/A |
| Other Noncurrent Nonfinancial Liabilities | N/A | 202,000.00 | N/A | 227,000.00 | N/A |
| Longterm Borrowings | N/A | 0.00 | N/A | 0.00 | 0.00 |
| Current Liabilities | N/A | 239,890,000.00 | N/A | 133,054,000.00 | N/A |
| Current Provisions | N/A | 1,902,000.00 | N/A | 2,328,000.00 | N/A |
| Trade And Other Current Payables | N/A | 146,348,000.00 | N/A | 104,807,000.00 | N/A |
| Current Tax Liabilities Current | N/A | 89,415,000.00 | N/A | 24,613,000.00 | N/A |
| Current Liabilities Other Than Liabilities Included In Disposal Groups Classified As Held For Sale | N/A | 239,890,000.00 | N/A | 133,054,000.00 | N/A |
| Liabilities Included In Disposal Groups Classified As Held For Sale | N/A | 0.00 | N/A | 0.00 | N/A |
| Current Borrowings And Current Portion Of Noncurrent Borrowings | N/A | 686,000.00 | N/A | 0.00 | 211,000.00 |
| Line item in (pln) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|
| Revenue | 1,834,174,000.00 | 1,727,349,000.00 | N/A |
| Other Income | 4,494,000.00 | 5,739,000.00 | N/A |
| Changes In Inventories Of Finished Goods And Work In Progress | -2,269,000.00 | -115,436,000.00 | N/A |
| Raw Materials And Consumables Used | 252,014,000.00 | 343,651,000.00 | N/A |
| Cost Of Merchandise Sold | 394,526,000.00 | 815,332,000.00 | 235,240,000.00 |
| Services Expense | 38,479,000.00 | 61,628,000.00 | 61,937,000.00 |
| Employee Benefits Expense | 78,438,000.00 | 86,104,000.00 | N/A |
| Depreciation And Amortisation Expense | 18,518,000.00 | 19,306,000.00 | N/A |
| Tax Expense Other Than Income Tax Expense | 1,327,000.00 | 1,234,000.00 | 1,386,000.00 |
| Other Expense By Nature | 3,815,000.00 | 3,956,000.00 | N/A |
| Profit Loss From Operating Activities | 1,047,621,000.00 | 463,433,000.00 | N/A |
| Finance Income | 929,000.00 | 22,388,000.00 | N/A |
| Finance Costs | 7,984,000.00 | 8,596,000.00 | N/A |
| Profit Loss Before Tax | 1,040,566,000.00 | 477,225,000.00 | N/A |
| Income Tax Expense Continuing Operations | 104,997,000.00 | 32,373,000.00 | N/A |
| Profit Loss From Continuing Operations | 935,569,000.00 | 444,852,000.00 | N/A |
| Profit Loss From Discontinued Operations | 0.00 | 0.00 | N/A |
| Profit (loss) | 935,569,000.00 | 444,852,000.00 | -190,786,000.00 |
| Profit Loss Attributable To Owners Of Parent | 930,185,000.00 | 446,865,000.00 | N/A |
| Profit Loss Attributable To Noncontrolling Interests | 5,384,000.00 | -2,013,000.00 | N/A |
| Line item in (pln) | 01.01.2021 | 02.01.2020 | 01.01.2022 | 02.01.2021 | 01.01.2023 |
|---|---|---|---|---|---|
| Profit (loss) | 935,569,000.00 | N/A | 444,852,000.00 | N/A | -190,786,000.00 |
| Adjustments For Reconcile Profit Loss | -205,651,000.00 | N/A | 178,134,000.00 | N/A | N/A |
| Adjustments For Decrease Increase In Inventories | -117,585,000.00 | N/A | -23,395,000.00 | N/A | N/A |
| Adjustments For Depreciation And Amortisation Expense | 18,518,000.00 | N/A | 19,306,000.00 | N/A | N/A |
| Adjustments For Provisions | 3,360,000.00 | N/A | 2,881,000.00 | N/A | N/A |
| Adjustments For Unrealised Foreign Exchange Losses Gains | 49,000.00 | N/A | 1,077,000.00 | N/A | N/A |
| Adjustments For Losses Gains On Disposal Of Noncurrent Assets | -205,000.00 | N/A | 5,939,000.00 | N/A | N/A |
| Other Adjustments To Reconcile Profit Loss | -8,227,000.00 | N/A | -6,958,000.00 | N/A | N/A |
| Adjustments For Reconcile Profit Loss | -205,651,000.00 | N/A | 178,134,000.00 | N/A | N/A |
| Cash Flows From Used In Operations | 729,918,000.00 | N/A | 622,986,000.00 | N/A | N/A |
| Income Taxes Paid Refund Classified As Operating Activities | 17,449,000.00 | N/A | 119,986,000.00 | N/A | N/A |
| Cash Flows From Used In Operating Activities | 712,469,000.00 | N/A | 503,000,000.00 | N/A | N/A |
| Interest Received Classified As Investing Activities | 224,000.00 | N/A | 388,000.00 | N/A | N/A |
| Cash Flows From Used In Investing Activities | -161,270,000.00 | N/A | -230,045,000.00 | N/A | N/A |
| Proceeds From Issuing Shares | 270,000.00 | N/A | 747,000.00 | N/A | N/A |
| Payments To Acquire Or Redeem Entitys Shares | 10,639,000.00 | N/A | 332,082,000.00 | N/A | N/A |
| Proceeds From Borrowings Classified As Financing Activities | 0.00 | N/A | 0.00 | N/A | N/A |
| Repayments Of Borrowings Classified As Financing Activities | 141,883,000.00 | N/A | 717,000.00 | N/A | N/A |
| Payments Of Lease Liabilities Classified As Financing Activities | 1,417,000.00 | N/A | 1,742,000.00 | N/A | N/A |
| Dividends Paid Classified As Financing Activities | 8,193,000.00 | N/A | 0.00 | N/A | N/A |
| Interest Paid Classified As Financing Activities | 4,231,000.00 | N/A | 117,000.00 | N/A | N/A |
| Cash Flows From Used In Financing Activities | -166,093,000.00 | N/A | -333,911,000.00 | N/A | N/A |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | 385,106,000.00 | N/A | -60,956,000.00 | N/A | -107,332,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | -49,000.00 | N/A | 722,000.00 | N/A | N/A |
| Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | 385,057,000.00 | N/A | -60,234,000.00 | N/A | -116,262,000.00 |
| Cash and cash equivalents | 399,840,000.00 | 14,783,000.00 | 339,606,000.00 | 399,840,000.00 | 223,344,000.00 |
Please note that some sums might not add up.
PLMRCTR00015
LEI259400YONW18M3H4WX66
SectorHealth Care Equipment & Services
IndustryHealth Care Equipment & Supplies
Sub-IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.